These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34333132)

  • 1. The pathology of early failure in Mitroflow pericardial valve bioprosthesis (12A/LX).
    Della Barbera M; Valente M; Basso C; Pettenazzo E; Thiene G
    Cardiovasc Pathol; 2021; 55():107373. PubMed ID: 34333132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients.
    Sénage T; Le Tourneau T; Foucher Y; Pattier S; Cueff C; Michel M; Serfaty JM; Mugniot A; Périgaud C; Carton HF; Al Habash O; Baron O; Roussel JC
    Circulation; 2014 Dec; 130(23):2012-20. PubMed ID: 25355912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of the Pericarbon bovine pericardial xenograft implanted in humans.
    Valente M; Ius P; Bortolotti U; Talenti E; Bottio T; Thiene G
    J Heart Valve Dis; 1998 Mar; 7(2):180-9. PubMed ID: 9587859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bioprostheses anti-calcification treatment: comparative follow-up between Mitroflow LX and Magna pericardial xenografts using a propensity score-weighted analysis.
    Blasco-Lucas A; Permanyer E; Pérez ML; Gracia-Baena JM; Ríos R; Casós K; Galiñanes M
    Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):335-341. PubMed ID: 28040770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunction.
    Ius F; Schulz J; Roumieh M; Fleissner F; Ismail I; Tudorache I; Warnecke G; Martens A; Shrestha M; Boethig D; Haverich A; Cebotari S
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):264-271. PubMed ID: 28838100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis.
    García-Bengochea J; Sierra J; González-Juanatey JR; Rubio J; Vega M; Fernández AL; Sánchez D
    J Heart Valve Dis; 2006 May; 15(3):446-51; discussion 451-2. PubMed ID: 16784087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitroflow pericardial bioprosthesis: structured failure at 4.5 years.
    Butany J; Feng T; Suri R; Law K; Christakis G
    Cardiovasc Pathol; 2012; 21(6):506-10. PubMed ID: 23137773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of aortic bioprostheses: An 18-year experience.
    Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of failure of the Mitroflow pericardial valve.
    Leandri J; Bertrand P; Mazzucotelli JP; Loisance D
    J Heart Valve Dis; 1992 Nov; 1(2):225-31. PubMed ID: 1341633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of transcatheter valve-in-valve replacement for Mitroflow bioprosthetic valve dysfunction.
    Mosquera VX; González-Barbeito M; Bouzas-Mosquera A; Herrera-Noreña JM; Velasco C; Salgado-Fernández J; Calviño-Santos R; Vázquez-González N; Vázquez-Rodríguez JM; Cuenca-Castillo JJ
    J Card Surg; 2018 Jul; 33(7):356-362. PubMed ID: 29790206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants.
    Bottio T; Thiene G; Pettenazzo E; Ius P; Bortolotti U; Rizzoli G; Valfré C; Casarotto D; Valente M
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):99-105. PubMed ID: 12878944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic evaluation of 28 Mitroflow pericardial valves: a 12-year experience.
    Luk A; Cusimano RJ; Butany J
    Ann Thorac Surg; 2015 Jan; 99(1):48-54. PubMed ID: 25442994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.
    Axtell AL; Chang DC; Melnitchouk S; Jassar AS; Tolis G; Villavicencio MA; Sundt TM; D'Alessandro DA
    J Card Surg; 2018 Dec; 33(12):778-786. PubMed ID: 30525247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitroflow aortic pericardial bioprosthesis--clinical performance.
    Jamieson WR; Koerfer R; Yankah CA; Zittermann A; Hayden RI; Ling H; Hetzer R; Dolman WB
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):818-24. PubMed ID: 19700338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes and Durability of the Mitroflow Aortic Bioprosthesis.
    Mosquera VX; Bouzas-Mosquera A; Velasco-García C; Muñiz J; Estévez-Cid F; Portela-Torron F; Herrera-Noreña JM; Cuenca-Castillo JJ
    J Card Surg; 2016 May; 31(5):264-73. PubMed ID: 26991888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults.
    Saleeb SF; Newburger JW; Geva T; Baird CW; Gauvreau K; Padera RF; Del Nido PJ; Borisuk MJ; Sanders SP; Mayer JE
    Circulation; 2014 Jul; 130(1):51-60. PubMed ID: 24756063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity.
    Waziri F; Karunanithi Z; Løgstrup BB; Hjortdal V; Nielsen PH; Poulsen SH
    J Cardiothorac Surg; 2019 Mar; 14(1):62. PubMed ID: 30885227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly.
    Alvarez JR; Sierra J; Vega M; Adrio B; Martinez-Comendador J; Gude F; Martinez-Cereijo J; Garcia J
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):842-6. PubMed ID: 19679611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitroflow pericardial valve prosthesis in the aortic position: an analysis of long-term outcome and prognostic factors.
    Minami K; Boethig D; Mirow N; Kleikamp G; Koertke H; Godehardt E; Koerfer R
    J Heart Valve Dis; 2000 Jan; 9(1):112-22. PubMed ID: 10678383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.